Literature DB >> 28440535

Socioeconomic status and its relationship to chronic respiratory disease.

Sonu Sahni, Ankoor Talwar, Sameer Khanijo, Arunabh Talwar1.   

Abstract

Socioeconomic status (SES) is defined as an individual's social or economic standing, and is a measure of an individual's or family's social or economic position or rank in a social group. It is a composite of several measures including income, education, occupation, location of residence or housing. Studies have found a lower SES has been linked to disproportionate access to health care in many diseases. There is emerging data in pulmonary diseases such as COPD, asthma, cystic fibrosis, pulmonary hypertension and other chronic respiratory conditions that allude to a similar observation noted in other chronic diseases. In the setting of COPD, SES has an inverse relationship with COPD prevalence, mortality, health utilization costs and HRQoL. Asthma and cystic fibrosis show an increased severity and hospitalizations in relationship to a lower SES. Similar observations were seen in sarcoidosis, PHTN and obstructive sleep apnea. There remains a limited data on non-CF bronchiectasis and interstitial lung diseases. Population SES may be gauged by various measures such as education, occupation, marital status but no value is more indicative than income. Currently guidelines and management algorithms do not factor the effect of SES in the disease process. Despite the great amount of data available, a standardized method must be created to include SES in the prognostic calculations and management of chronic pulmonary diseases.

Entities:  

Keywords:  access to health care; chronic respiratory disease; disease severity; pulmonary disease; socioeconomic status

Mesh:

Year:  2017        PMID: 28440535     DOI: 10.5603/ARM.2017.0016

Source DB:  PubMed          Journal:  Adv Respir Med        ISSN: 2451-4934


  24 in total

1.  Trends in socio-economic inequalities in bladder cancer incidence in Canada: 1992-2010.

Authors:  Ryan Densmore; Mohammad Hajizadeh; Min Hu
Journal:  Can J Public Health       Date:  2019-06-17

Review 2.  Pathobiological mechanisms underlying metabolic syndrome (MetS) in chronic obstructive pulmonary disease (COPD): clinical significance and therapeutic strategies.

Authors:  Stanley M H Chan; Stavros Selemidis; Steven Bozinovski; Ross Vlahos
Journal:  Pharmacol Ther       Date:  2019-02-26       Impact factor: 12.310

3.  Asthma, Chronic Obstructive Pulmonary Disease, and Subsequent Risk for Incident Rheumatoid Arthritis Among Women: A Prospective Cohort Study.

Authors:  Julia A Ford; Xinyi Liu; Su H Chu; Bing Lu; Michael H Cho; Edwin K Silverman; Karen H Costenbader; Carlos A Camargo; Jeffrey A Sparks
Journal:  Arthritis Rheumatol       Date:  2020-04-03       Impact factor: 10.995

4.  The effect of the socioeconomic status on the measurement of asthma control.

Authors:  Preetam Ganti; Annya Suman; Shivani Chaudhary; Brijit Sangha; Larick David; Sudhir Sekhsaria
Journal:  Allergy Asthma Proc       Date:  2022-01-01       Impact factor: 2.587

5.  Treatment Patterns, Socioeconomic Status and Clinical Burden in Mild COPD: A Swedish Real-World, Retrospective Cohort Study, the ARCTIC Study.

Authors:  Kjell Larsson; Karin Lisspers; Björn Ställberg; Gunnar Johansson; Florian S Gutzwiller; Karen Mezzi; Bine Kjoeller Bjerregaard; Leif Jorgensen; Hyewon Koo; Christer Janson
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-06-21

Review 6.  Health Disparities in Patients with Pulmonary Arterial Hypertension: A Blueprint for Action. An Official American Thoracic Society Statement.

Authors:  Arunabh Talwar; Joe G N Garcia; Halley Tsai; Matthew Moreno; Tim Lahm; Roham T Zamanian; Roberto Machado; Steven M Kawut; Mona Selej; Stephen Mathai; Laura Hoyt D'Anna; Sonu Sahni; Erik J Rodriquez; Richard Channick; Karen Fagan; Michael Gray; Jessica Armstrong; Josanna Rodriguez Lopez; Vinicio de Jesus Perez
Journal:  Am J Respir Crit Care Med       Date:  2017-10-15       Impact factor: 21.405

7.  The association between living below the relative poverty line and the prevalence of chronic obstructive pulmonary disease.

Authors:  Young Seok Lee; Jee Youn Oh; Kyung Hoon Min; Sung Yong Lee; Kyung Ho Kang; Jae Jeong Shim
Journal:  J Thorac Dis       Date:  2019-02       Impact factor: 2.895

8.  The disease burden of bronchiectasis in comparison with chronic obstructive pulmonary disease: a national database study in Korea.

Authors:  Bumhee Yang; Hayoung Choi; Jun Hyeok Lim; Hye Yun Park; Danbee Kang; Juhee Cho; Jae Seung Lee; Sei Won Lee; Yeon-Mok Oh; Ji-Yong Moon; Sang-Heon Kim; Tae-Hyung Kim; Jang Won Sohn; Ho Joo Yoon; Hyun Lee
Journal:  Ann Transl Med       Date:  2019-12

9.  Contribution of Individual and Neighborhood Factors to Racial Disparities in Respiratory Outcomes.

Authors:  Chinedu O Ejike; Han Woo; Panagis Galiatsatos; Laura M Paulin; Jerry A Krishnan; Christopher B Cooper; David J Couper; Richard E Kanner; Russell P Bowler; Eric A Hoffman; Alejandro P Comellas; Gerard J Criner; R Graham Barr; Fernando J Martinez; MeiLan K Han; Carlos H Martinez; Victor E Ortega; Trisha M Parekh; Stephanie A Christenson; Neeta Thakur; Aaron Baugh; Daniel C Belz; Sarath Raju; Amanda J Gassett; Joel D Kaufman; Nirupama Putcha; Nadia N Hansel
Journal:  Am J Respir Crit Care Med       Date:  2021-04-15       Impact factor: 30.528

10.  Sociodemographic and clinical factors affecting the quality of life of patients with chronic obstructive pulmonary disease.

Authors:  Joanna Rosińczuk; Maria Przyszlak; Izabella Uchmanowicz
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.